Lykos Therapeutics (formerly MAPS PBC)
Ari Kellner is a Licensed Clinical Psychologist with extensive experience in psychoanalysis and psychotherapy, currently serving in the MDMA Therapy Training Program at MAPS Public Benefit Corporation since August 2021, teaching an in-depth curriculum on MDMA-assisted therapy. Since January 2013, Ari has also contributed as a faculty member at the Westchester Center for the Study of Psychoanalysis and Psychotherapy, teaching a child development class focused on Infant Research, Neurosciences, and Psychodynamics. A dedicated practitioner since 2002, Ari operates a private practice providing outpatient psychoanalysis and psychotherapy for diverse populations, including children, adolescents, adults, and couples. Previous roles include primary therapist positions at the Mental Health Association of Westchester and North Central Bronx Hospital, along with experience as a school psychology extern within the educational system. Ari holds a Doctor of Psychology degree from Pace University and a certificate in Psychoanalysis from the Westchester Center for the Study of Psychoanalysis and Psychotherapy.
This person is not in any teams
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.